Evidence map›Paper›PMID 30711529›Full record

ReviewInternational journal of radiation oncology, biology, physics2019

NCTN Assessment on Current Applications of Radiomics in Oncology.

Ke Nie, Hania Al-Hallaq, X Allen Li, Stanley H Benedict, Jason W Sohn, Jean M Moran, Yong Fan, Mi Huang, Michael V Knopp, Jeff M Michalski and 8 more

Abstract readReview
In one paragraph

Review in International journal of radiation oncology, biology, physics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Ke NieDepartment of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers-Robert Wood Johnson Medical School, New Brunswick, New Jersey. Electronic address: Kn231@cinj.rutgers.edu.
Hania Al-HallaqDepartment of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois.
X Allen LiDepartment of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Stanley H BenedictDepartment of Radiation Oncology, University of California-Davis, Sacramento, California.
Jason W SohnDepartment of Radiation Oncology, Allegheny Health Network, Pittsburgh, Pennsylvania.
Jean M MoranDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Yong FanDepartment of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Mi HuangDepartment of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Michael V KnoppDivision of Imaging Science, Department of Radiology, Ohio State University, Columbus, Ohio.
Jeff M MichalskiDepartment of Radiation Oncology, Washington University School of Medicine in St. Louis, St. Louis, Missouri.
James MonroeDepartment of Radiation Oncology, St. Anthony's Cancer Center, St. Louis, Missouri.
Ceferino ObcemeaRadiation Research Program, National Cancer Institute, Bethesda, Maryland.
Christina I TsienDepartment of Radiation Oncology, Washington University School of Medicine in St. Louis, St. Louis, Missouri.
Timothy SolbergDepartment of Radiation Oncology, University of California-San Francisco, San Francisco, California.
Jackie WuDepartment of Radiation Oncology, Duke University, Durham, North Carolina.
Ping XiaDepartment of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio.
Ying XiaoDepartment of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Issam El NaqaDepartment of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois.

Funding

NRG Oncology Network Group Operations Center - GY9 BIQSFP Reports/BudgetsU10CA180868 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI NORMAN WOLMARK · 2014 to 2026
$206.8M
Statistics CoreU10CA180822 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Elaina Harper · 2014 to 2026
$146.4M
IROC: Enhancing local enrolling site radiological data capture capabilities for NCTN trialsU24CA180803 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI Thomas J. FitzGerald, MICHAEL V KNOPP · 2014 to 2026
$116.2M
UM LAPs -UG1 GrantUG1CA233160 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANNE F SCHOTT · 2019 to 2026
$5.4M
Learning radiomic signatures to early predict response of rectal cancer patients to neoadjuvant chemoradiation therapyR21CA223358 · NCI · UNIVERSITY OF PENNSYLVANIA · PI FAN, YONG · 2018 to 2019
$380k
NCI NIH HHS R21 CA223358NCI NIH HHS U10 CA180822NCI NIH HHS U10 CA180868NCI NIH HHS U24 CA180803NCI NIH HHS UG1 CA233160
6 · The paper itself

Abstract

Radiomics is a fast-growing research area based on converting standard-of-care imaging into quantitative minable data and building subsequent predictive models to personalize treatment. Radiomics has been proposed as a study objective in clinical trial concepts and a potential biomarker for stratifying patients across interventional treatment arms. In recognizing the growing importance of radiomics in oncology, a group of medical physicists and clinicians from NRG Oncology reviewed the current status of the field and identified critical issues, providing a general assessment and early recommendations for incorporation in oncology studies.

Indexed as

Decision Support Systems, ClinicalGenomicsHumansImage Processing, Computer-AssistedLogistic ModelsMachine LearningMagnetic Resonance ImagingNeoplasmsPhantoms, ImagingPharmacokineticsPhenotypePositron-Emission TomographyRadiation OncologyReproducibility of ResultsTomography, X-Ray ComputedTreatment Outcome

Identifiers

PMID30711529
PMCPMC6499656

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.